ABSTRACT
Previous studies on the effects of ethanol on circulating pituitary hormones have been carried out mostly during daytime when the secretion of these hormones is generally at a nadir. Therefore, we studied the effects of ethanol on the nocturnal secretion of GH, PRL. TSH, and thyroid hormones (protocol I, nine healthy subjects, five women) and on the TSH and PRL responses to synthetic TRH (protocol II, healthy subjects, four women). Ethanol was given in doses of 0,0.5, or 1.0 g/kg of BW (protocol I) and 0 or 1.0 g/kg (protocol 111 and ingested po at 1900-1945 h. In protocol I, plasma GH rose from 0.6 ? 0.2 pg/L (mean 2 SE) at 2200 h to 25.0 2 4.3 pg/L at 0100 h in control subjects and was almost completely inhibited at 4.5 i-1.7 pg/L at 0100 h in subjects receiving 1.0 g/kg ethanol (P < 0.011. In subjects receiving 0.5 g/kg ethanol, the inhibition was also significant (P < 0.011, plasma GH being 8.2 2 2.5 pg/L at 0100 h. Plasma GHRH was measured after solid phase separation in RIA, but it did not show any ethanol-related changes. Plasma PRL exhibited a clear diurnal rhythm in control subjects and rose from 77 2 16 at 1800 h to 248 2 62 pg/L at 0700 h (P < 0.01). The plasma PRL profile was not affected by ethanol.
Plasma TSH was 1.4 2 0.2 mu/L at 1800-2200 h and rose to 2.3-2.4 mU/L for 0100-0700 h (P < 0.001) in the control subjects. Ethanol 1.0 g/kg suppressed plasma TSH to 1.4 + 0.2 mU/L (P < 0.05 at 0100 h and P < 0.01 at 0200 h). According to the area under the curve analyses, the suppression in the nocturnal TSH was 32% in the 0.5 g/kg group and 45% in the 1.0 g/kg group (P < 0.05 for both cases).
Circulating free or total T, and T, did not show any statistically significant changes that could explain the ethanol-induced inhibition in the nocturnal TSH peak. In protocol II, synthetic TRH (1 /&kg BW) was given intravenously, and blood samples were collected before, at 20 and 60 min. TRH significantly stimulated plasma TSH and PRL, but ethanol (1.0 g/kg BWl had no effect on these responses. (J Clin Endocrinol Metab 81: 2627-2632, 1996) S ERUM CONCENTRATIONS of pituitary hormones exhibit well-known diurnal rhythms in adult man. The secretion of GH peaks at night, approximately 1.5-2 h after falling asleep, and the total amount of GH secreted during the night is several times greater than the amount released during the daytime (l-3). PRL shows an initial rise 60-90 min after falling asleep and reaches maximal levels at 0500-0700 h (4). Circulating TSH also presents a diurnal rhythm with elevated nighttime levels (5-7); the mean TSH pulse amplitude increases at night by 82% and 92% in men and women, respectively (8). It is evident that the rhythmic patterns in the release of pituitary hormones depend on environmental cues and on endogenous oscillators in the brain where various transmitters and releasing hormones bring about these physiological rhythms.
Administration of ethanol results in deleterious effects on physical and mental performance, and these effects are believed to be mediated by ethanol-induced interference with cell membrane functions and synaptic transmission in the central nervous system. For example, ethanol is known to increase y-aminobutyric acid activity and to decrease the affinity of P-receptors in the brain (9,101. We have recently shown that the administration of small or moderate doses of ethanol delayed the nyctohemeral melatonin surge but stimulated the secretion of noradrenaline and P-endorphin during early evening and night (11, 12) . Most previous studies on the effects of ethanol on other pituitary hormones have been carried out during the daytime. In these studies, ethanol has been found to suppress the daytime secretion of GH, but the changes have been small (13, 141, or no changes have been observed (151. Instead, a substantial reduction in nocturnal GH levels by ethanol has been reported in one study in which ethanol was given in the evening and blood samples taken during night (16). Data on the effects of ethanol on PRL secretion are inconsistent and mostly daytime levels have been measured. It has been demonstrated that ethanol stimulates PRL secretion (17-191, but contradictory findings have also been reported (14, (20) (21) (22) BW mixed in a sugar-free carbonated drink (600 mL) at l-week intervals.
The amount of ethanol of the 0.5-g/kgdose is 35 g in a 70-kg subject and represents approximately the amount of alcohol present in a half liter bottle of wine with a concentration of 7%. The subjects arrived at the site of the trial at 1700 h, at which time a cannula was inserted in a dorsal vein of the hand. Heparin 5000 IU/lOO mL (Medica, Helsinki, Finland) in physiological sodium solution (200 PL) was used to keep the cannulae open. The drinks were given at 1900 h and were to be consumed at a constant pace by 1945 h. The blood sampling was started at 1800 h (before intake of alcohol or vehicle) followed by samples at 2000, 2200, 2400, 0100, 0200, 0300, 0400, and 0700 h. Lights were turned off at 2300 h, at which time the subjects were asked to go to bed. The blood samples were thereafter taken in the dark (under 2 lux). The subjects had been fasting since 1500 h and received a standardized snack containing bread, butter, cheese, 0.2 L of orange juice, and a banana at 2100 h.
Protocol II was an open, randomized experiment carried out after the information of protocol I was available. Each of the six subjects received po 0 or 1.0 g ethanol/kg
BW mixed in a drink as in protocol I. The 0-min blood sample was taken between 2250 and 2310 h from the subjects, and immediately thereafter 1 pg of synthetic TRH/kg BW (Relefact TRH, Hoechst, Frankfurt am Main, Germany) was given iv. The following blood samples were taken at 20 and 60 min from the injection of TRH. All subjects completed the study and no serious adverse effects or differences in sleep habits between the control and experimental subjects were observed.
Biochemical assays
Blood was taken into EDTA tubes for GH, GHRH, PRL, TSH, T,, free T4 (ET,), T,, and free T, (ET,) measurements, and into glass tubes for serum ethanol measurements.
The tubes were centrifuged within 30 min and the plasma and sera stored at -70 C. GHRH from the solid-phase plasma extracts was analyzed by RIA (25). Plasma GH was analyzed by a kit from Pharmacia (Uuusala, Sweden Protocol I
Results
The serum ethanol concentrations (data not shown) peaked at 2000 h, 1 h after the start of the ethanol intake, i.e 13.1 ? 1.1 mmol/L (mean ? SE, n = 9) and 26.8 2 1.8 mmol/L in subjects receiving 0.5 and 1.0 g of ethanol/kg BW, respectively (P < 0.001 between the groups). Thereafter serum ethanol decreased to undetectable levels (~0.4 mmol/L) in both groups within 5 h and 11 h, respectively.
Subjects from the control sessions also had undetectable serum ethanol levels.
In the control group, plasma GH was 8.4 t 1.6 kg/L at 1800 h and decreased to 0.6 + 0.2 pg/L at 2200 h. These relatively high GH levels at 1800 h most probably present a small GH peak in the evening in the wakeful state as reported earlier (25). After midnight, plasma GH presented an expected large peak, 25.0 t 4.3 pg/L at 0100 h. Ethanol had no significant effects on plasma GH at 2000 h or at 2200 h until at 0100 h and 0200 h, when the higher dose (1.0 g/kg) almost completely inhibited the nocturnal GH peak (P < 0.01, Fig.  1A ). The lower dose also decreased nocturnal GH levels at 0100 h and 0200 h, but to a lesser degree (P < 0.01, Fig. 1A ). In the subjects receiving the lower ethanol dose, plasma GH was significantly higher (P < 0.05) than the control value at 0400 h, possibly because of a rebound phenomenon. In the control subjects plasma immunoreactive GHRH showed a diurnal variation, so that the levels at 0200, 0400, and 0700 h were significantly (P < 0.01, Fig. 1B ) lower than those at 1800 h in the control subjects. No significant changes were found in plasma GHRH (Fig. 1B) after ethanol administration. Plasma TSH ( Fig. 2A) showed a significant (P < 0.01) nyctohemeral rhythm in the control group. It was 1.4 ? 0.2 mU/L at 1800 h, and the nocturnal rise began after 2200 h, reaching maximal levels of 2.4 ? 0.4 mU/L at 01.00 h and remaining high until morning (2.1 2 0.3 mU/L at 0700 h). We were able to show that the higher dose of ethanol inhibited the nocturnal TSH increase. The inhibition was significant at 0100 (P < 0.05) and 0200 h (P < 0.01) with plasma TSH concentrations of 1.4 +-0.2 mu/L. Although there were decreases after the lower dose, these were not significant. Plasma PRL levels (Fig. 2B ) in the control subjects were at the same level at 1800-2200 h, 60-80 pg/L, whereafter they gradually increased to 105 at midnight and to 248 pg/L at 0700 h (P < 0.001). Interestingly, ethanol had no significant effect on plasma PRL in our study. Figure 3 shows the ethanol-induced inhibition of nocturnal PRL, TSH, and GH secretions based on AUC analyses. When the relative area under the plasma GH curve between 2200 and 0300 h was taken as 100% in the control group, the lower and higher ethanol dose reduced the nocturnal GH surge to 37% and 20%, respectively (P < 0.01 for both cases). Correspondingly, when the relative area under TSH curves between 2200 and 0700 h was taken as 100% in the control subjects, the inhibition was 32% and 45% in subjects receiving 0.5 g/kg and 1.0 g/kg ethanol, respectively (P < 0.05 for both cases). Ethanol had no effects on PRL secretion as measured by AUC analyses, confirming our plasma measurements. When we observed that ethanol resulted in a significant inhibition of plasma TSH after midnight, we wanted to know if this inhibition was preceded by an increase in the plasma levels of thyroid hormones. Because of the much longer half-lives, measurements on 2-4 time points in each test group were carried out. Plasma T, (Fig. 4A ) measured at 1800 and 0700 h or ET, (Fig. 4B ) measured at 1800,2200,0300, and of ethanol in 600 mL of beverage between 1900 and 1945 h. *, P < 0.05 VS. controls. a TRH was given 1 pg/kg BW at time 0 min, and TSH and PRL prolactin were measured 20 and 60 min thereafter.
'P < 0.01 vs. before values. Note that there were no significant changes in TSH or PRL responses between ethanol-and vehicletreated subjects.
pg/kg BW, totaling 55-88 pg/subject) led to a 5.5-fold increase at 20 min and a 4.2-fold increase at 60 min in the control subjects, and to 5.4-and 4.4-fold increases in the ethanol-treated subjects, respectively (P < 0.01 in both cases). There were no significant changes between control and ethanol-treated subjects. Synthetic TRH led to significant increases in plasma PRL but no significant differences were found between control subjects and ethanol-treated subjects (Table 1) .
Discussion
Ethanol administration has been shown to result in diminished circulating GH levels in studies carried out in the evening or at night. For example, an earlier study from this laboratory demonstrated that large doses of ethanol (1.5 g/kg BW) inhibited the small evening surge of GH (13) but no nighttime measurements were performed. Later, acute and chronic effects of ethanol (0.8 g/kg) on sleep pattern and GH secretion were studied and it was found that ethanol decreased nighttime GH secretion by 70% (16). We observed in this study that ethanol caused a significant and dosedependent decrease in plasma GH levels during 4 h after midnight and, what is more important, the abolition of the nocturnal GH surge was almost total (80% after the dose of ethanol 1.0 g/kg BW). The lower dose also led to a substantial (63%) inhibition at 0100 h when ethanol had disappeared from circulation.
Thus, our present results agree with those of Prinz et al. (16) and show, in addition, that a relatively small ethanol dose (0.5 g/kg) corresponding to the amount of ethanol present in half a bottle of wine, also effectively suppresses nocturnal GH secretion. We wish to emphasize that the suppression was evident although there was no longer any ethanol detectable in serum, indicating that ethanol had caused a long-lasting (up to 8 h) interference with a cellular mechanism related to the nocturnal GH surge. We have previously found that in peripubertal children the majority of nocturnal GHRH pulses precedes or coincides with GH pulses (26). Therefore we also measured plasma GHRH and observed that plasma GHRH levels before the nocturnal GH surge were stable. Evidently the long sampling interval in our present study (l-4 h) did not make it possible to detect the pulsatile secretion of GHRH. Anyway, plasma GHRH in subjects receiving vehicle only was significantly lower at 0400 and 0700 h than between 1800-0100 h, indicating the presence of a diurnal rhythm in the secretion of GHRH. We found no changes in circulating immunoreactive GHRH levels after ethanol administration, suggesting that the GH suppressing effect of ethanol could be mainly mediated by factors other than hypothalamic GHRH. However, small changes in portal GHRH caused by ethanol could be lost when peripheral GHRH is monitored as in our present study. According to previous studies carried out in experimental animals, ethanol seems to have multiple effects: it inhibits GH and GHRH gene expression (27, 28) and signal transduction in the pituitary somatotrophs (29). In man, GH response to synthetic GHRH was similar in vehicle-and ethanol-treated subjects (301, indicating a suprapituitary mechanism for the ethanol-induced inhibition of GH. The effects of ethanol on the GHRH-GH axis may have important clinical implications on growth and development in children. It is known that maternal alcohol abuse leads to fetal alcohol syndrome associated with intrauterine growth retardation and slow postnatal growth (31). This phenomenon might be caused by the inhibitory effect of ethanol on GH secretion that we describe in this study, although other factors such as nutrition are also important. The main evidence comes from animal studies: animals fed with ethanol-containing diets exhibit decreased growth even when food intake and other nutritional factors are controlled (32). In our control subjects (both females and males) plasma PRL was low between 1800 and 2200 h, but thereafter it gradually increased, reaching its maximum (a 4-fold rise) the next morning.
Our results are in accordance with previous studies on a diurnal rhythm in circulating PRL: the peak values have been observed at night and especially in early morning (4). In the present study, we observed no effect of ethanol either on the nocturnal PRL secretion or PRL response to synthetic TRH. These results differ from those performed during daytime when increased (17-19) or decreased (14, 20-22) PRL levels have been observed after alcohol intake. In a previous report, the PRL response to TRH was similar in control and ethanol-exposed healthy subjects at 4 h from the beginning of the alcohol intake but blunted at 14 h (15). Also, PRL responses to physical stimuli such as breast stimulation (23), hyperthermia (33), or synthetic TRH in alcoholics (34) are reduced after ethanol intake. Taken together, these findings suggest that ethanol appears to have an inhibitory effect on PRL secretion, but the inhibitory effect cannot be seen during nighttime.
To our knowledge the present study is the first to show an acute inhibitory effect of ethanol on the nocturnal TSH surge in healthy volunteers as judged from the plasma TSH measurements and AUC analyses. There are previous human studies that partly describe the effect of ethanol on nocturnal TSH secretion (13, 15). However, in both studies TSH was monitored only until midnight and no changes were observed. Therefore the reason for these negative results may be that TSH levels were not followed long enough. In another previous report, nighttime levels of plasma TSH were measured after ethanol intake, but all the samples were pooled and no significant differences were observed between control night and first ethanol night (24). In the aforementioned study ethanol (0.8 g/kg) was ingested late in the evening, which also explains why it did not have any effects.
If the regulation principles of TSH secretion are taken into account, the decrease in plasma TSH by ethanol may be caused by elevated levels of thyroid hormones or caused by central mechanisms.
Therefore we studied the effects of ethanol on the serum levels of free and total thyroid hormones and found no significant changes before plasma TSH was inhibited.
We also performed a TRH stimulation test by using low TRH doses. We reasoned that the usual TRH dose (200 pg/subject) may be too high, so that the possible ethanolinduced inhibition at the pituitary thyrotrope level may not be detected. Therefore we used TRH doses that were 55-88 pg (adjusted for BW). These TRH doses led to greater than 5-fold increases in plasma TSH, but the TSH response did not change after ethanol intake. Thus our present results suggest that there is a central mechanism behind the ethanol-induced TSH decrease.
The adenohypophyseal secretion of TSH and PRL are under the control of hypothalamus, principally of dopamine, but also of TRH. 
